Reliant Challenges Abbott's TriCor Patents

Law360, New York (June 4, 2004, 12:00 AM EDT) -- Reliant Pharmaceuticals Inc. has filed a lawsuit against Abbott Laboratories, asking a federal judge to invalidate four anti-cholesterol drug patents.

In a suit filed in U.S. District Court for the District of Delaware last week, Reliant says it plans to sell a version of Abbott's TriCor capsules, and that it expects Abbott and the original patent owner, Laboratoires Fournier of France, to sue for patent infringement.

The patents for the drug are unenforceable because the inventors failed to tell the U.S. Patent and Trademark Office about...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.